SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-065288
Filing Date
2020-03-09
Accepted
2020-03-06 18:09:33
Documents
2
Period of Report
2020-03-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d846972d8k.htm 8-K 26171
2 EX-2.1 d846972dex21.htm EX-2.1 21625
  Complete submission text file 0001193125-20-065288.txt   48989
Mailing Address 3 CENTER PLAZA SUITE 610 BOSTON MA 02108
Business Address 3 CENTER PLAZA SUITE 610 BOSTON MA 02108 617-622-4003
ZAFGEN, INC. (Filer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36510 | Film No.: 20696083
SIC: 2834 Pharmaceutical Preparations